Indian Pharma Can’t Catch a Break

The Signal Daily

Dec 18 2023 • 7 mins

After made-in-India cough syrups were implicated in the deaths of at least 141 children in Cameroon, Gambia, and Uzbekistan, and made-in-India eye-drops were recalled in the US and Sri Lanka due to contamination, a recent Bloomberg Businessweek investigation has now linked a made-in-India anticancer drug to the deaths of at least four children in Colombia.

Also, in today’s episode, expectant mothers in India are turning to a cluster of apps to help them continue the tradition of educating children while they are still in the womb. In other words, it's the making of Abhimanyu in digital India.

The Signal Daily is produced in association with IVM.
The episode was researched and written by Dhruv Sharma and Anup Semwal
Edited by Venkat Ananth
Produced by Manaswini
Mastered and mixed by Manas and Nirvaan

See omnystudio.com/listener for privacy information.

You Might Like

The Morning Brief
The Morning Brief
The Economic Times
ANI Podcast with Smita Prakash
ANI Podcast with Smita Prakash
Asian News International (ANI)
ThePrint
ThePrint
ThePrint
3 Things
3 Things
Express Audio
FT News Briefing
FT News Briefing
Financial Times
Economist Podcasts
Economist Podcasts
The Economist
Daybreak
Daybreak
The Ken
Global News Podcast
Global News Podcast
BBC World Service
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
Top of the Morning
Top of the Morning
Mint - HT Smartcast
The Daily
The Daily
The New York Times
The Journal.
The Journal.
The Wall Street Journal & Gimlet
WSJ What’s News
WSJ What’s News
The Wall Street Journal
WSJ Tech News Briefing
WSJ Tech News Briefing
The Wall Street Journal
Serial
Serial
Serial Productions & The New York Times